Local Institution - 0013

Madrid 28050

1 studies enrolling now · 2 studies all time

What they study most

Advanced Cancer, Advanced Renal Cell Carcinoma (RCC)

Studies at this site

• A Study to Evaluate the Safety, Tolerability, and Efficacy of Pumitamig Alone or in Combination With Ipilimumab or Cabozantinib in Participants With Advanced Renal Cell Carcinoma (RCC) (ROSETTA RCC-208) — Recruiting now
• First-In-Human Study of Monoclonal Antibody BMS-986218 by Itself and in Combination With Nivolumab in Participants With Advanced Solid Tumors — Stopped early